The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cardiopulmonary Bypass

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cardiopulmonary Bypass


Psychiatry related information on Cardiopulmonary Bypass


High impact information on Cardiopulmonary Bypass


Chemical compound and disease context of Cardiopulmonary Bypass


Biological context of Cardiopulmonary Bypass


Anatomical context of Cardiopulmonary Bypass


Associations of Cardiopulmonary Bypass with chemical compounds


Gene context of Cardiopulmonary Bypass


Analytical, diagnostic and therapeutic context of Cardiopulmonary Bypass


  1. Venovenous bypass with a membrane lung to support bilateral lung lavage. Zapol, W.M., Wilson, R., Hales, C., Fish, D., Castorena, G., Hilgenberg, A., Quinn, D., Kradin, R. JAMA (1984) [Pubmed]
  2. Metastatic Wilms' tumor causing acute hepatic-vein occlusion (Budd-Chiari syndrome). Schraut, W.H., Chilcote, R.R. Gastroenterology (1985) [Pubmed]
  3. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia. Pouplard, C., May, M.A., Iochmann, S., Amiral, J., Vissac, A.M., Marchand, M., Gruel, Y. Circulation (1999) [Pubmed]
  4. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Rosenzweig, E.B., Starc, T.J., Chen, J.M., Cullinane, S., Timchak, D.M., Gersony, W.M., Landry, D.W., Galantowicz, M.E. Circulation (1999) [Pubmed]
  5. Occurrence of oxidative stress during reperfusion of the human heart. Ferrari, R., Alfieri, O., Curello, S., Ceconi, C., Cargnoni, A., Marzollo, P., Pardini, A., Caradonna, E., Visioli, O. Circulation (1990) [Pubmed]
  6. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time. Shore-Lesserson, L., Manspeizer, H.E., Bolastig, M., Harrington, D., Vela-Cantos, F., DePerio, M. Anesth. Analg. (2000) [Pubmed]
  7. Thyroid hormone treatment after coronary-artery bypass surgery. Klemperer, J.D., Klein, I., Gomez, M., Helm, R.E., Ojamaa, K., Thomas, S.J., Isom, O.W., Krieger, K. N. Engl. J. Med. (1995) [Pubmed]
  8. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. Salzman, E.W., Weinstein, M.J., Weintraub, R.M., Ware, J.A., Thurer, R.L., Robertson, L., Donovan, A., Gaffney, T., Bertele, V., Troll, J. N. Engl. J. Med. (1986) [Pubmed]
  9. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. Chenoweth, D.E., Cooper, S.W., Hugli, T.E., Stewart, R.W., Blackstone, E.H., Kirklin, J.W. N. Engl. J. Med. (1981) [Pubmed]
  10. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. Rinder, C.S., Rinder, H.M., Smith, B.R., Fitch, J.C., Smith, M.J., Tracey, J.B., Matis, L.A., Squinto, S.P., Rollins, S.A. J. Clin. Invest. (1995) [Pubmed]
  11. Effect of prostacyclin on vascular capacity in the dog. Fulghum, T.G., DiMarco, J.P., Supple, E.W., Nash, I., Gendlerman, J., Eton, D.F., Newell, J.B., Zusman, R.M., Powell, W.J. J. Clin. Invest. (1985) [Pubmed]
  12. Adenosine reduces postbypass transfusion requirements in humans after heart surgery. Mentzer, R.M., Rahko, P.S., Canver, C.C., Chopra, P.S., Love, R.B., Cook, T.D., Hegge, M.O., Lasley, R.D. Ann. Surg. (1996) [Pubmed]
  13. Acute renal failure after cardiovascular surgery. Current concepts in pathophysiology, prevention and treatment. Leurs, P.B., Mulder, A.W., Fiers, H.A., Hoorntje, S.J. Eur. Heart J. (1989) [Pubmed]
  14. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass. Pretorius, M., Scholl, F.G., McFarlane, J.A., Murphey, L.J., Brown, N.J. Clin. Pharmacol. Ther. (2005) [Pubmed]
  15. Ceftriaxone disposition in open-heart surgery patients. Jungbluth, G.L., Pasko, M.T., Beam, T.R., Jusko, W.J. Antimicrob. Agents Chemother. (1989) [Pubmed]
  16. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Lango, R., Smolenski, R.T., Narkiewicz, M., Suchorzewska, J., Lysiak-Szydlowska, W. Cardiovasc. Res. (2001) [Pubmed]
  17. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin. Koshal, A., Krausz, M.M., Utsunomiya, T., Hechtman, H.B., Collins, J.J., Cohn, L.H. Circulation (1981) [Pubmed]
  18. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Ovrum, E., Brosstad, F., Am Holen, E., Tangen, G., Abdelnoor, M. Circulation (1995) [Pubmed]
  19. Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Weinstein, M., Ware, J.A., Troll, J., Salzman, E. Blood (1988) [Pubmed]
  20. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Hiraoka, H., Yamamoto, K., Okano, N., Morita, T., Goto, F., Horiuchi, R. Clin. Pharmacol. Ther. (2004) [Pubmed]
  21. Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Blauth, C., Arnold, J., Kohner, E.M., Taylor, K.M. Lancet (1986) [Pubmed]
  22. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Fitch, J.C., Rollins, S., Matis, L., Alford, B., Aranki, S., Collard, C.D., Dewar, M., Elefteriades, J., Hines, R., Kopf, G., Kraker, P., Li, L., O'Hara, R., Rinder, C., Rinder, H., Shaw, R., Smith, B., Stahl, G., Shernan, S.K. Circulation (1999) [Pubmed]
  23. Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Burns, S.A., Newburger, J.W., Xiao, M., Mayer, J.E., Walsh, A.Z., Neufeld, E.J. Circulation (1995) [Pubmed]
  24. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Khan, M.M., Hattori, T., Niewiarowski, S., Edmunds, L.H., Colman, R.W. Thromb. Haemost. (2006) [Pubmed]
  25. Cardiopulmonary bypass with a low-molecular-weight heparin fraction. Gouault-Heilmann, M., Huet, Y., Contant, G., Payen, D., Bloch, G., Rapin, M. Lancet (1983) [Pubmed]
  26. Valvular-ventricular interaction: importance of the mitral apparatus in canine left ventricular systolic performance. Hansen, D.E., Cahill, P.D., DeCampli, W.M., Harrison, D.C., Derby, G.C., Mitchell, R.S., Miller, D.C. Circulation (1986) [Pubmed]
  27. Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Davies, G.C., Sobel, M., Salzman, E.W. Circulation (1980) [Pubmed]
  28. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Belhomme, D., Peynet, J., Louzy, M., Launay, J.M., Kitakaze, M., Menasché, P. Circulation (1999) [Pubmed]
  29. Induction of interleukin-8 expression during cardiopulmonary bypass. Kalfin, R.E., Engelman, R.M., Rousou, J.A., Flack, J.E., Deaton, D.W., Kreutzer, D.L., Das, D.K. Circulation (1993) [Pubmed]
  30. Evidence for development of capillary leak syndrome associated with cardiopulmonary bypass in pediatric patients with the homozygous C4A null phenotype. Zhang, S., Wang, S., Yao, S. Anesthesiology (2004) [Pubmed]
  31. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Roth-Isigkeit, A., Hasselbach, L., Ocklitz, E., Brückner, S., Ros, A., Gehring, H., Schmucker, P., Rink, L., Seyfarth, M. Clin. Exp. Immunol. (2001) [Pubmed]
  32. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Tabardel, Y., Duchateau, J., Schmartz, D., Marécaux, G., Shahla, M., Barvais, L., Leclerc, J.L., Vincent, J.L. Surgery (1996) [Pubmed]
  33. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. McBride, W.T., Armstrong, M.A., Crockard, A.D., McMurray, T.J., Rea, J.M. British journal of anaesthesia. (1995) [Pubmed]
  34. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds. Longmore, D.B., Bennett, G., Gueirrara, D., Smith, M., Bunting, S., Moncada, S., Reed, P., Read, N.G., Vane, J.R. Lancet (1979) [Pubmed]
  35. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Teoh, K.H., Bradley, C.A., Gauldie, J., Burrows, H. Circulation (1995) [Pubmed]
  36. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Tofukuji, M., Metais, C., Li, J., Franklin, A., Simons, M., Sellke, F.W. Circulation (1998) [Pubmed]
  37. Nafamostat mesilate reduces blood loss during open heart surgery. Murase, M., Usui, A., Tomita, Y., Maeda, M., Koyama, T., Abe, T. Circulation (1993) [Pubmed]
  38. Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. Malpass, T.W., Hanson, S.R., Savage, B., Hessel, E.A., Harker, L.A. Blood (1981) [Pubmed]
WikiGenes - Universities